Viewing StudyNCT00352378



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00352378
Status: COMPLETED
Last Update Posted: 2011-06-27
First Post: 2006-07-13

Brief Title: Primary Chemotherapy With AdriamycinCyclophosphamideAC vs TaxotereXelodaTX for Stage II and III Breast Cancer
Sponsor:
Organization: National Cancer Center Korea